🇺🇸 FDA
Patent

US 9498511

Methods related to the treatment of neurodegenerative and inflammatory conditions

granted A61KA61K31/19A61K31/46

Quick answer

US patent 9498511 (Methods related to the treatment of neurodegenerative and inflammatory conditions) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/19, A61K31/46, A61K31/485, A61K38/06